A detailed history of Ubs Group Ag transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 101,032 shares of AMPH stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,032
Previous 122,681 17.65%
Holding current value
$3.95 Million
Previous $4.91 Million 0.08%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $800,796 - $1.08 Million
-21,649 Reduced 17.65%
101,032 $4.9 Million
Q2 2024

Aug 13, 2024

BUY
$38.65 - $43.48 $1.63 Million - $1.84 Million
42,229 Added 52.49%
122,681 $4.91 Million
Q1 2024

May 13, 2024

BUY
$42.85 - $63.45 $401,333 - $594,272
9,366 Added 13.18%
80,452 $3.53 Million
Q4 2023

Feb 09, 2024

BUY
$44.49 - $62.93 $2.35 Million - $3.32 Million
52,714 Added 286.93%
71,086 $4.4 Million
Q3 2023

Nov 09, 2023

BUY
$45.51 - $65.0 $160,377 - $229,060
3,524 Added 23.73%
18,372 $844,000
Q2 2023

Aug 11, 2023

SELL
$35.77 - $58.38 $291,239 - $475,329
-8,142 Reduced 35.42%
14,848 $853,000
Q1 2023

May 12, 2023

BUY
$27.99 - $37.92 $165,588 - $224,334
5,916 Added 34.65%
22,990 $862,000
Q4 2022

Feb 08, 2023

BUY
$27.93 - $31.27 $45,358 - $50,782
1,624 Added 10.51%
17,074 $478,000
Q3 2022

Nov 10, 2022

SELL
$27.56 - $37.75 $333,090 - $456,246
-12,086 Reduced 43.89%
15,450 $434,000
Q2 2022

Aug 10, 2022

SELL
$29.79 - $42.29 $10,515 - $14,928
-353 Reduced 1.27%
27,536 $958,000
Q1 2022

May 16, 2022

BUY
$22.96 - $36.45 $332,254 - $527,467
14,471 Added 107.85%
27,889 $1 Million
Q4 2021

Feb 14, 2022

BUY
$18.14 - $23.29 $75,426 - $96,839
4,158 Added 44.9%
13,418 $313,000
Q3 2021

Nov 15, 2021

SELL
$17.83 - $21.49 $385,609 - $464,764
-21,627 Reduced 70.02%
9,260 $176,000
Q2 2021

Aug 13, 2021

SELL
$17.11 - $20.92 $189,168 - $231,291
-11,056 Reduced 26.36%
30,887 $623,000
Q1 2021

May 12, 2021

SELL
$17.21 - $20.65 $17,863 - $21,434
-1,038 Reduced 2.42%
41,943 $769,000
Q4 2020

Feb 11, 2021

BUY
$17.76 - $21.24 $460,516 - $550,753
25,930 Added 152.07%
42,981 $865,000
Q3 2020

Nov 12, 2020

SELL
$17.99 - $22.22 $332,653 - $410,870
-18,491 Reduced 52.03%
17,051 $320,000
Q2 2020

Jul 31, 2020

BUY
$14.25 - $22.46 $66,447 - $104,730
4,663 Added 15.1%
35,542 $798,000
Q1 2020

May 01, 2020

SELL
$12.66 - $20.08 $437,846 - $694,466
-34,585 Reduced 52.83%
30,879 $458,000
Q4 2019

Feb 14, 2020

BUY
$17.07 - $20.64 $34,071 - $41,197
1,996 Added 3.14%
65,464 $1.26 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $22.62 $203,283 - $240,495
10,632 Added 20.12%
63,468 $1.26 Million
Q2 2019

Aug 14, 2019

BUY
$18.92 - $22.96 $191,281 - $232,125
10,110 Added 23.66%
52,836 $1.12 Million
Q1 2019

May 14, 2019

BUY
$19.46 - $25.28 $559,085 - $726,294
28,730 Added 205.27%
42,726 $873,000
Q4 2018

Feb 14, 2019

SELL
$17.72 - $22.51 $18,375 - $23,342
-1,037 Reduced 6.9%
13,996 $278,000
Q3 2018

Nov 14, 2018

BUY
$15.39 - $19.38 $181,571 - $228,645
11,798 Added 364.7%
15,033 $289,000
Q2 2018

Aug 14, 2018

SELL
$14.63 - $19.6 $54,306 - $72,755
-3,712 Reduced 53.43%
3,235 $49,000
Q1 2018

May 15, 2018

BUY
$17.23 - $20.35 $6,064 - $7,163
352 Added 5.34%
6,947 $131,000
Q4 2017

Feb 14, 2018

BUY
$17.76 - $19.75 $36,052 - $40,092
2,030 Added 44.47%
6,595 $127,000
Q3 2017

Nov 14, 2017

SELL
$14.73 - $17.99 $43,659 - $53,322
-2,964 Reduced 39.37%
4,565 $82,000
Q2 2017

Aug 14, 2017

SELL
N/A
-1,820 Reduced 19.47%
7,529 $134,000
Q1 2017

Nov 14, 2017

BUY
N/A
9,349
9,349 $136,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.